These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15080848)

  • 1. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.
    Bloom S; Kiilerich S; Lassen MR; Forbes A; Leiper K; Langholz E; Irvine EJ; O'Morain C; Lowson D; Orm S
    Aliment Pharmacol Ther; 2004 Apr; 19(8):871-8. PubMed ID: 15080848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy.
    Siguret V; Gouin-Thibault I; Pautas E; Leizorovicz A
    J Thromb Haemost; 2011 Oct; 9(10):1966-72. PubMed ID: 21819539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
    Gray LJ; Sprigg N; Bath PM; Sørensen P; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein B; van der Sande JJ; Turpie AG;
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):327-33. PubMed ID: 16046439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Venous Thromboprophylaxis With Low-molecular-weight Heparin in Children With Ulcerative Colitis.
    Story E; Bijelic V; Penney C; Benchimol EI; Halton J; Mack DR
    J Pediatr Gastroenterol Nutr; 2021 Nov; 73(5):604-609. PubMed ID: 34676833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study.
    Gouin-Thibault I; Mansour A; Caribotti C; Pierre-Jean M; Bouzille G; Ballerie A; Maucorps L; Gueret P; Nédelec-Gac F; Pontis A; Mahé G; Vannier S; Behar N; Cardiet I; Mismetti P; Frouget T; Delavenne X
    J Thromb Haemost; 2024 Jul; ():. PubMed ID: 39019439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalised cutaneous necrosis: a complication of low-molecular-weight heparin.
    Patel GK; Knight AG
    Int Wound J; 2005 Sep; 2(3):267-70. PubMed ID: 16618332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis.
    Yazeji T; Moulari B; Beduneau A; Stein V; Dietrich D; Pellequer Y; Lamprecht A
    Drug Deliv; 2017 Nov; 24(1):811-817. PubMed ID: 28509629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days.
    Gouin-Thibault I; Pautas E; Depasse F; Andreux JP; Siguret V
    J Thromb Haemost; 2003 Dec; 1(12):2694-5. PubMed ID: 14675115
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled pilot study: effect of carrageenan emulsifier on inflammation and gastrointestinal symptoms in quiescent ulcerative colitis.
    Laatikainen R; Lehto M; Mäkelä-Salmi N; Hillilä M; Groop PH; Salmenkari H
    Food Nutr Res; 2023; 67():. PubMed ID: 37920677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population.
    Saleem A; Zeeshan M; Hazoor F; Mustafa G
    Pak J Med Sci; 2022; 38(1):276-280. PubMed ID: 35035439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study.
    Harvey B; Lafrance JP; Elftouh N; Vallée M; Laurin LP; Nadeau-Fredette AC
    Kidney360; 2023 May; 4(5):641-647. PubMed ID: 36921585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbial Transplant in Children With Ulcerative Colitis: A Randomized, Double Blinded, Placebo-Controlled Pilot Study: Retraction.
    J Pediatr Gastroenterol Nutr; 2018 May; ():. PubMed ID: 29787456
    [No Abstract]   [Full Text] [Related]  

  • 13. Fecal Microbial Transplant In Children With Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study: Retracted.
    Michail S
    J Pediatr Gastroenterol Nutr; 2018 May; ():. PubMed ID: 28991839
    [No Abstract]   [Full Text] [Related]  

  • 14. Mild to moderate ulcerative colitis: Call me by my name.
    Rodríguez-Lago I; Barreiro-de Acosta M
    United European Gastroenterol J; 2022 Nov; 10(9):919-920. PubMed ID: 36031778
    [No Abstract]   [Full Text] [Related]  

  • 15. Ulcerative colltis in the older patient- a treatment conundrum.
    Goh KL
    JGH Open; 2021 Aug; 5(8):841. PubMed ID: 34386589
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.
    Celasco G; Papa A; Jones R; Moro L; Bozzella R; Surace MM; Naccari GC; Gasbarrini G
    Aliment Pharmacol Ther; 2010 Feb; 31(3):375-86. PubMed ID: 19891665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; Wang Y; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2015 Aug; 8(8):CD006774. PubMed ID: 35658167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Yarlas A; Maher S; Bayliss M; Lovley A; Cappelleri JC; Bushmakin AG; DiBonaventura MD
    J Patient Cent Res Rev; 2020; 7(2):189-205. PubMed ID: 32377552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.
    Patel RP; Shastri MD; Ming LC; Zaidi STR; Peterson GM
    Front Pharmacol; 2018; 9():586. PubMed ID: 29922163
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.